Drugs / MK-8876
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01930058 | Oct 2013 → May 2014 | hepatitis C virus infection | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MK-8876 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01930058 ↗ |
| Modality | Small molecule | — CHEMBL3931672 ↗ |
| Route | Oral | “by mouth” NCT01930058 ↗ |